Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy
- Conditions
- Total Laparoscopic Hysterectomy
- Registration Number
- NCT06867614
- Lead Sponsor
- Ain Shams University
- Brief Summary
The goal of this clinical trial is to compare the laparoscopic and transvaginal closure techniques of the vaginal vault in patients who perform TLH, regarding the risk of vaginal vault hematoma and other complications as vaginal cuff infection and sexual dysfunction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 48
- Adult females consenting to do TLH all age groups with diagnoses of benign uterine conditions.
- Women who are non-obese (normal or overweight women with BMI range 18-29.9).
- Sexually active female.
- Diagnosed cases of pelvic malignancy
- Diagnosed patients with Cervical intraepithelial neoplasia (CIN) or bacterial vaginosis (any infection should be treated)
- Obese patients.
- Patients currently undergoing treatment for any type of cancer
- Patients with coagulopathy, bleeding/clotting disorders
- Patients with any condition can impair wound healing: diabetes mellites, anemia, steroids
- Patients with a previous history of radiation and allergy to sutures
- Patients with clinically evident prolapse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Vaginal Vault hematoma From 10 days postoperative to 30 days postoperative It will be assessed by examination and ultrasound
- Secondary Outcome Measures
Name Time Method Bleeding/spotting From 10 days postoperative to 30 days postoperative I wil be assed by history and examination
Vaginal infection: From 10 days postoperative to 30 days postoperative It will be assessed by history and examination
Vaginal prolapse From 10 days postoperative to 30 days postoperative It will be assessed by history and examination
Vaginal cuff granulation From 10 days postoperative to 30 days postoperative It will be assessed by examination and ultrasound
Sexual dysfunction From 3 to 4 months post operative I will be assessed through Female Sexual Function Index (FSFI) questionnaire
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ain Shams University maternity hospital
🇪🇬Cairo, Egypt
Ain Shams University maternity hospital🇪🇬Cairo, Egypt